Cardinal Health Builds On Generic Device Strategy With Cordis Deal

The $1.99 billion Cordis acquisition is a major step in Cardinal's strategy to build its offerings of devices with a high physician preference but for which there is limited clinical differentiation and inefficient supply chains.